Regeneron Pharmaceuticals
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 39 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Regeneron Pharmaceuticals as a sponsor: 39 trials, 19 as lead sponsor and 20 as collaborator.
Phase and status
| Phase | Recruiting | Not yet recruiting | Active, not recruiting | Completed | All statuses |
|---|---|---|---|---|---|
| Phase 2 | 2 | 0 | 1 | 4 | 7 |
| Phase 2/3 | 0 | 0 | 0 | 1 | 1 |
| Phase 3 | 7 | 1 | 0 | 20 | 28 |
| Phase 4 | 0 | 0 | 0 | 3 | 3 |
| All phases | 9 | 1 | 1 | 28 | 39 |
Start year
| Start year | Trials |
|---|---|
| 2026 | 8 |
| 2025 | 2 |
| 2023 | 2 |
| 2020 | 1 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 4 |
| 2015 | 4 |
| 2014 | 1 |
| 2013 | 4 |
| 2012 | 9 |
| 2011 | 1 |
Main conditions
Main countries
- United States
- Canada
- France
- Japan
- United Kingdom
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Regeneron Pharmaceuticals
- Sponsor class
- INDUSTRY
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 39
Record details
- Record id
cardio:org-regeneron-pharmaceuticals- Content hash
cd486243adae1c4cd986d8713748d12d754bae0ccd9a863fd1b4e62af63e4224